COP
51
-2
EMC
70
12
URBN
70
7
PRGO
66
9
LOW
55
6
APH
73
2
LYB
55
18
TXN
40
4
EIX
54
-4
HAS
57
-3
VZ
30
3
PNR
72
10
TXT
66
3
AMT
41
-4
HCA
35
-9
PGR
70
-3
L
50
-5
PRU
47
-3
MSFT
60
5
PWR
76
2
COP
51
-2
EMC
70
12
URBN
70
7
PRGO
66
9
LOW
55
6
APH
73
2
LYB
55
18
TXN
40
4
EIX
54
-4
HAS
57
-3
VZ
30
3
PNR
72
10
TXT
66
3
AMT
41
-4
HCA
35
-9
PGR
70
-3
L
50
-5
PRU
47
-3
MSFT
60
5
PWR
76
2
Financhill
Back

GoodRx Holdings 10K Form

Buy
68

GDRX
GoodRx Holdings

Last Price:
7.19
Seasonality Move:
-19.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GDRX News And Ratings

See the #1 stock for the next 7 days that we like better than GDRX

GDRX Financial Statistics

Sales & Book Value

Annual Sales: $750.27M
Cash Flow: $3M
Price / Cash Flow: 35.79
Annual Sales: $1.93
Price / Book: 3.73

Profitability

EPS (TTM): -0.02000
Net Income (TTM): $-8.87M
Gross Margin: $683.34M
Return on Equity: -1.06%
Return on Assets: -0.54%

GoodRx Holdings Earnings Forecast

Key GoodRx Holdings Financial Ratios

  • The Gross Profit Margin over the past 6 years for GDRX is 91.08%.
  • The Selling, General & Administrative Expenses for GDRX have been equal to 62.22% of Gross Profit Margin.
  • The Research & Development expenses have been 18.11% of Revenue.
  • The Interest Expense is -639.69% of Operating Income.
  • The Net Earning history of GDRX is -1.18% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

GoodRx Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: GDRX
Website: goodrx.com

Debt

Debt-to-Equity Ratio: 0.86
Current Ratio: 7.12
Quick Ratio: 6.79

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 15.81

GDRX Technical Analysis vs Fundamental Analysis

Buy
68
GoodRx Holdings (GDRX) is a Buy

Is GoodRx Holdings a Buy or a Sell?

  • GoodRx Holdings stock is rated a Buy
    The current GoodRx Holdings [GDRX] share price is $7.19. The Score for GDRX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.